News

We are pleased to announce that Alba by Quotient continues to grow in Europe. It is now also available in the Czech Republic. Here are the geographies where Alba by Quotient is available: Alba by Quotient believes in creating value for laboratories, that’s why in addition to a portfolio of high-quality blood bank reagents, we…

We are delighted to announce that the new ALBA Elution Kit is now CE marked and will soon be available.  The ALBA Elution Kit for the acid elution of antibodies from intact red cells produces 10 elutions per kit, delivers a distinct pH change reaction, offers room temperature storage, user-friendly instructions, and minimal product waste.…

We are excited to announce that our abstract, titled “Performance characteristics of a new, fully automated planar microarray immunoassay for the detection of autoantibodies against Centromere Protein B and correlations with autoimmune disease diagnosis” will be presented at the 2023 Dresden Symposium on Autoantibodies, in Germany. The study demonstrated that the MosaiQ® Centromere Protein B…

Quotient and FAS Diagnostic Group, Inc. have signed a distribution agreement, which will enable FAS Diagnostic Group, Inc. to distribute Alba by Quotient® and MosaiQ® in the Philippines, Southeast Asia. The distribution agreement takes effect immediately. This strategic partnership reaffirms Quotient’s commitment to grow and expand its geographical presence. It will enable both parties to introduce…

We are excited to announce that we are in Bangkok, Thailand, from 16-18 August for Medlab Asia. Visit us in hall 6 of the IMPACT Exhibition Center, booth number B10 where our team of experts will be delighted to welcome you and give you an insight into our products that can support your laboratory needs.…

We are pleased to announce the next chapter of our exciting journey as a disruptive innovator in clinical diagnostics: Quotient is becoming AliveDx.   AliveDx is more than a name, it is a call to action. AliveDx brings urgency to the work that we do as leaders in innovation and healthcare. When we become ‘alive,’…

We are excited to announce that our abstract has been accepted by the 2023 AACC Annual Scientific Meeting & Clinical Expo in Anaheim, California. To read a copy of the abstract click here. A performance evaluation study conducted at Hôpital Pitié-Salpêtrière in Paris, France shows good performance on the comparison method for the MosaiQ® microarray immunoassay for…

We are pleased to announce that we have successfully passed the annual ISO 14001 Surveillance Audit for our Eysins site in Switzerland. The ISO 14001 is an internationally recognized standard for environmental management systems (EMS). This certification reaffirms the Eysins site’s dedication to maintaining high environmental performance and improving its environmental management practices. Quotient passed…

Quotient and Transmedic have signed a distribution agreement, which will enable Transmedic to distribute Alba by Quotient® and MosaiQ™ in five countries in Southeast Asia. This significant partnership reaffirms Quotient’s commitment to grow and expand its geographical presence. It will enable both parties to introduce new quality services to the healthcare industry in Southeast Asia…

We are pleased to announce that Alba by Quotient™ continues to grow in Europe and is now available in the Netherlands and Sweden in addition to the following geographies: Austria France Germany Greece Hungary Italy Luxembourg Netherlands Poland Romania Slovakia Sweden Alba by Quotient™ believes in creating value for laboratories, that’s why in addition to…